Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship
- PMID: 1331108
Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship
Abstract
In order to define the receptor binding site and the structure-functional relationship of tumor necrosis factor (TNF), single amino acid substitutions were made by site-directed mutagenesis at selected residues of human tumor necrosis factor, using a phagemid mutagenesis/expression vector. The recombinant TNF mutants were compared to the wild type TNF in assays using crude bacterial lysates, for protein yield, solubility, subunit trimerization, receptor binding inhibition activity, and in vitro cytotoxic activity. All mutants which did not form cross-linkable trimer also showed little cytotoxic activity or receptor binding inhibition activity, indicating that trimer formation is obligatory for TNF-alpha activity. Most mutations of internal residues yielded no cross-linkable trimer, while most mutations of surface residues yielded cross-linkable trimer. Mutations at surface residues Leu29, Arg31, and Ala35 yielded cross-linkable trimers with good activities, except proline substitutions which may cause conformational changes in the polypeptide chain. This suggested that these residues are near the receptor binding site. Mutations at other strictly conserved internal residues such as Ser60, His78, and Tyr119 form cross-linkable trimer with little activity. These mutations may indirectly affect the receptor binding site by forming trimers with undetectable abnormalities. Mutants of surface residues Tyr87, Ser95, Ser133, and Ser147 affect receptor binding and cytotoxic activity but not trimer formation, suggesting that these residues are involved directly in receptor binding. The fact that residues Arg31, Ala35, Tyr87, Ser95, and Ser147, located on the opposite sides of a monomer, are clustered at the intersubunit grooves of TNF trimer supports the current notion that TNF receptor binding sites are trivalent and are located at the three intersubunit grooves. However, our finding that Ser133, which is outside the groove, can also be involved directly in receptor binding suggested that the receptor binding sites of TNF may not be confined to the intersubunit grooves, but extended to include additional surface residues.
Similar articles
-
Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).Protein Eng. 1991 Oct;4(7):785-91. doi: 10.1093/protein/4.7.785. Protein Eng. 1991. PMID: 1665907
-
Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells.Lymphokine Cytokine Res. 1993 Jun;12(3):173-80. Lymphokine Cytokine Res. 1993. PMID: 7688581
-
Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.J Biol Chem. 1993 Dec 15;268(35):26350-7. J Biol Chem. 1993. PMID: 8253759
-
Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.J Biol Chem. 2001 Oct 5;276(40):37426-30. doi: 10.1074/jbc.M102020200. Epub 2001 Jul 11. J Biol Chem. 2001. PMID: 11448951
-
Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.J Biol Chem. 1991 Apr 25;266(12):7313-6. J Biol Chem. 1991. PMID: 1850405 Review. No abstract available.
Cited by
-
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):11879-84. doi: 10.1073/pnas.211178398. Proc Natl Acad Sci U S A. 2001. PMID: 11592999 Free PMC article.
-
Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.Can J Vet Res. 2001 Oct;65(4):233-40. Can J Vet Res. 2001. PMID: 11768130 Free PMC article.
-
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.Antimicrob Agents Chemother. 1999 May;43(5):1027-33. doi: 10.1128/AAC.43.5.1027. Antimicrob Agents Chemother. 1999. PMID: 10223910 Free PMC article.
-
Protection from tumor necrosis factor-mediated cytolysis by platelets.Am J Pathol. 1993 Dec;143(6):1713-23. Am J Pathol. 1993. PMID: 8256858 Free PMC article.
-
Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.Biosci Rep. 2013 Aug 23;33(4):e00060. doi: 10.1042/BSR20130044. Biosci Rep. 2013. PMID: 23863106 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources